Publication date: Jun 14, 2025
The goal of this proposal is to provide a first assessment of the efficacy of our innovative non-invasive brain stimulation system, kTMP, in the treatment of anhedonia in MDD.
| Concepts | Keywords |
|---|---|
| Autism | anhedonia |
| Drugs | Cortical Excitability |
| Hospitalization | kTMP |
| Innovative | Major Depressive Disorder |
| Pregnancy | Neuroscience |
| NIBS | |
| Plasticity | |
| reward network |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Anhedonia |
| disease | MESH | Major Depressive Disorder |
| disease | MESH | psychotic disorder |
| disease | MESH | bipolar disorder |
| disease | MESH | post-traumatic stress disorder |
| disease | MESH | schizophrenia |
| disease | MESH | autism spectrum disorders |
| disease | MESH | mental retardation |
| disease | MESH | substance use disorder |
| disease | MESH | ideation suicidal |
| disease | MESH | suicide |
| disease | MESH | seizure |
| drug | DRUGBANK | Ethanol |
| disease | MESH | Contraindications |
Original Article
(Visited 12 times, 1 visits today)